研究者
J-GLOBAL ID:201801020800760193
更新日: 2025年03月27日 横尾 健
ヨコオ タケシ | Yokoo Takeshi
- Natsuki Ishikawa, Yusuke Watanabe, Yuichirou Maeda, Tomoaki Yoshida, Naruhiro Kimura, Hiroyuki Abe, Akira Sakamaki, Hiroteru Kamimura, Takeshi Yokoo, Kenya Kamimura, et al. Human placental extract improves liver cirrhosis in mice with regulation of macrophages and senescent cells. Regenerative therapy. 2025. 28. 509-516
- Tatsuo Kanda, Reina Sasaki-Tanaka, Naruhiro Kimura, Hiroyuki Abe, Tomoaki Yoshida, Kazunao Hayashi, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Atsunori Tsuchiya, et al. Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review. International journal of molecular sciences. 2025. 26. 5
- Shunta Yakubo, Hiroyuki Abe, Yawen Li, Marina Kudo, Atsushi Kimura, Takuya Wakabayashi, Yusuke Watanabe, Naruhiro Kimura, Toru Setsu, Takeshi Yokoo, et al. Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model. Diseases (Basel, Switzerland). 2024. 12. 12
- Shun Yamazaki, Yusuke Watanabe, Kazuya Takahashi, Kentaro Tominaga, Satoshi Ikarashi, Takeshi Yokoo, Hiroteru Kamimura, Atsunori Tsuchiya, Shuji Terai. Diffuse Large B-cell Lymphoma with Severe Lactic Acidosis and Liver Failure: A Case Report and Literature Review. Internal medicine (Tokyo, Japan). 2024
- Yuichirou Maeda, Yusuke Watanabe, Natsuki Ishikawa, Tomoaki Yoshida, Naruhiro Kimura, Hiroyuki Abe, Akira Sakamaki, Hiroteru Kamimura, Takeshi Yokoo, Kenya Kamimura, et al. Platelet-rich plasma-derived extracellular vesicles improve liver cirrhosis in mice. Regenerative therapy. 2024. 26. 1048-1057
- 阿部 寛幸, 弥久保 俊太, 渡邉 雄介, 木村 成宏, 横尾 健, 坂牧 僚, 上村 博輝, 土屋 淳紀, 上村 顕也, 寺井 崇二. ダサチニブ及びケルセチンは老化細胞除去剤としてMASHメダカモデルにおいて老化細胞を減少させ病態改善に寄与する. 肝臓. 2024. 65. Suppl.1. A514-A514
- 阿部 寛幸, 弥久保 俊太, 渡邉 雄介, 木村 成宏, 横尾 健, 坂牧 僚, 上村 博輝, 土屋 淳紀, 上村 顕也, 寺井 崇二. ダサチニブ及びケルセチンは老化細胞除去剤としてMASHメダカモデルにおいて老化細胞を減少させ病態改善に寄与する. 肝臓. 2024. 65. Suppl.1. A514-A514
- Masayoshi Ko, Kenya Kamimura, Takashi Owaki, Takuro Nagoya, Norihiro Sakai, Itsuo Nagayama, Yusuke Niwa, Osamu Shibata, Chiyumi Oda, Shinichi Morita, et al. Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver. Disease models & mechanisms. 2023. 16. 12
- Itsuo Nagayama, Kenya Kamimura, Takashi Owaki, Masayoshi Ko, Takuro Nagoya, Yuto Tanaka, Marina Ohkoshi, Toru Setsu, Akira Sakamaki, Takeshi Yokoo, et al. Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease. Hepatology international. 2023
- Yuto Tanaka, Kenya Kamimura, Osamu Shibata, Kohei Ogawa, Chiyumi Oda, Hiroyuki Abe, Satoshi Ikarashi, Kazunao Hayashi, Takeshi Yokoo, Toshifumi Wakai, et al. Similarity of oncogenic protein expression in KRASG12D gene delivery-based rat pancreatic cancer model to that of human pancreatic cancer. Biochemical and biophysical research communications. 2023. 673. 29-35
- Naruhiro Kimura, Kazuya Takahashi, Toru Setsu, Yusuke Horibata, Yusuke Kaneko, Haruka Miyazaki, Kohei Ogawa, Yuzo Kawata, Norihiro Sakai, Yusuke Watanabe, et al. Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis. Hepatology research : the official journal of the Japan Society of Hepatology. 2023
- 荒生 祥尚, 酒井 規裕, 薛 徹, 渡邉 雄介, 木村 成宏, 阿部 寛幸, 坂牧 僚, 上村 博輝, 横尾 健, 土屋 淳紀, et al. 多職種の肝炎医療コーディネーターとの連携による,院内におけるC型肝炎患者の拾い上げと紹介率向上の効果. 肝臓. 2023. 64. Suppl.2. A634-A634
- Kenya Kamimura, Tsutomu Kanefuji, Takeshi Suda, Takeshi Yokoo, Guisheng Zhang, Yutaka Aoyagi, Dexi Liu. Liver lobe-specific hydrodynamic gene delivery to baboons: A preclinical trial for hemophilia gene therapy. Molecular therapy. Nucleic acids. 2023. 32. 903-913
- Naruhiro Kimura, Kazuya Takahashi, Toru Setsu, Shu Goto, Suguru Miida, Nobutaka Takeda, Yuichi Kojima, Yoshihisa Arao, Kazunao Hayashi, Norihiro Sakai, et al. Machine learning prediction model for treatment responders in patients with primary biliary cholangitis. JGH open : an open access journal of gastroenterology and hepatology. 2023. 7. 6. 431-438
- Takeshi Suda, Takeshi Yokoo, Tsutomu Kanefuji, Kenya Kamimura, Guisheng Zhang, Dexi Liu. Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances. Pharmaceutics. 2023. 15. 4
- 薛 徹, 上村 博輝, 坂牧 僚, 横尾 健, 上村 顕也, 土屋 淳紀, 高村 昌明, 寺井 崇二. 急性肝不全に対する治療 内科,外科の立場から 新潟県での急性肝不全診療ネットワークの構築とOn line HD導入への取り組み. 肝臓. 2023. 64. 2. 92-93
- Yusuke Watanabe, Hiroyuki Abe, Naruhiro Kimura, Yoshihisa Arao, Natsuki Ishikawa, Maeda Yuichiro, Toru Setsu, Akira Sakamaki, Hiroteru Kamimura, Takeshi Yokoo, et al. Navitoclax improves acute-on-chronic liver failure by eliminating senescent cells in mice. Hepatology research : the official journal of the Japan Society of Hepatology. 2023. 53. 5. 460-472
- Chiyumi Oda, Kenya Kamimura, Osamu Shibata, Shinichi Morita, Yuto Tanaka, Toru Setsu, Hiroyuki Abe, Takeshi Yokoo, Akira Sakamaki, Hiroteru Kamimura, et al. HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma. Biochemistry and biophysics reports. 2022. 32. 101352-101352
- Norihiro Sakai, Kenya Kamimura, Hirotaka Miyamoto, Masayoshi Ko, Takuro Nagoya, Toru Setsu, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Hiroyuki Soki, et al. Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression. Journal of gastroenterology. 2022. 58. 1. 53-68
- 横尾 健, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 上村 博輝, 坂牧 僚, 上村 顕也, et al. アテゾリズマブ+ベバシズマブ併用療法の非奏効例におけるLate line移行時期についての検討. 肝臓. 2022. 63. Suppl.2. A582-A582
前のページに戻る